whitepaper evolvalor
On this edition of Evolvalor market insights we focus on the life sciences and biotechnology sector, covering Venture Capital investment preferences.

This insight paper covers insights in Venture Capital investment preferences regarding biotechnology innovation. It sheds light on VCs’ behaviour and strategies regarding technology fields and therapeutic areas, in which they are invested most, combined with insights into investment priorities and investment barriers. This paper is particularly insightful for bioentrepreneurs, attempting to raise capital, as well as other life sciences investors.

So let’s talk


Send us an e-mail at or call us on +31 (0) 85 4014 704 and make sure to follow us on LinkedIn